XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - Immunization, Authority Hl7

42,405 resources

By Version

R2: 0
R2B: 0
R3: 2,217
R4: 26,023
R4B: 2,734
R5: 11,207
R6: 224

By Realm

none: 3,411
au: 272
be: 387
ca: 138
ch: 1,482
cl: 469
cr: 45
cz: 384
de: 190
dk: 88
ee: 155
eu: 1,173
fi: 87
fr: 120
in: 29
it: 181
kr: 5
nl: 929
no: 26
nz: 79
pl: 83
se: 22
stt: 116
us: 17,481
uv: 14,773
vn: 107
other: 7

Start Prev Rows 30200 - 30400 Next

Package	Version	Identity	Name/Title	Status	Date	Realm
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1105	Varicella Zoster	active	2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1106	Varicella Zoster Vaccine (VZV) Administered	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107	Varicella Zoster Vaccine (VZV) Administered	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1109	Hepatitis A Vaccine Administered	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1110	Hepatitis A Vaccine Administered	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1111	Hepatitis B Vaccine Administered	active	2021-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1112	Hepatitis B Vaccine Administered	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115	Child Influenza Vaccine Administered	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116	Child Influenza Vaccine Administered	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1117	Inactivated Polio Vaccine (IPV) Administered	active	2021-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1118	Inactivated Polio Vaccine (IPV) Administered	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1119	Pneumococcal Conjugate Vaccine Administered	active	2023-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1120	Rotavirus Vaccine (3 dose schedule) Administered	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1121	Rotavirus Vaccine (2 dose schedule) Administered	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1123	Genital Herpes	active	2024-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1124	Genital Herpes	active	2024-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1128	Lab Tests for Sexually Transmitted Infections	active	2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1129	Chlamydia Screening	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1133	Pneumococcal Conjugate Vaccine Administered	active	2024-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1135	HPV Test	active	2024-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1148	Rotavirus Vaccine (2 Dose Schedule) Administered	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1149	Rotavirus Vaccine (3 Dose Schedule) Administered	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1150	Advanced Illness	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1151	Advanced Illness	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1152	HiB Vaccine (3 dose schedule)	active	2021-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1153	HiB Vaccine (3 dose schedule) Administered	active	2021-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1154	HiB Vaccine (4 dose schedule)	active	2021-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1155	HiB Vaccine (4 dose schedule) Administered	active	2021-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156	HiB Vaccine (3 dose schedule) Administered	active	2024-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1157	HiB Vaccine (4 dose schedule) Administered	active	2024-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1158	Competing Conditions for Respiratory Conditions	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1159	Competing Conditions for Respiratory Conditions	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1022	DTaP Vaccine Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1024	Hepatitis A	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1031	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1032	Mumps	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1037	Rubella	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1039	Varicella Zoster	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1040	Varicella Zoster Vaccine (VZV) Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1041	Hepatitis A Vaccine Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1042	Hepatitis B Vaccine Administered	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044	Child Influenza Vaccine Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1045	Inactivated Polio Vaccine (IPV) Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1046	Pneumococcal Conjugate Vaccine Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1047	Rotavirus Vaccine (3 dose schedule) Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1048	Rotavirus Vaccine (2 dose schedule) Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1049	Genital Herpes	active	2018-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1051	Lab Tests for Sexually Transmitted Infections	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1052	Chlamydia Screening	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1053	Measles	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1059	HPV Test	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1082	Advanced Illness	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1083	Hib Vaccine (3 dose schedule)	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084	Hib Vaccine (3 dose schedule) Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1085	Hib Vaccine (4 dose schedule)	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1086	Hib Vaccine (4 dose schedule) Administered	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1087	Influenza Virus LAIV Vaccine	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1088	Influenza Virus LAIV Vaccine Administered	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1012	Lab Tests During Pregnancy	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1013	Diagnostic Studies During Pregnancy	active	2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1019	Pregnancy Test	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1022	Complications of Pregnancy, Childbirth and the Puerperium	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1023	Complications of Pregnancy, Childbirth and the Puerperium	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1028	Procedures for Sexual Activity	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1030	Procedures for Sexual Activity	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1031	Diagnosis for Sexual Activity	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1032	Diagnosis for Sexual Activity	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1033	Procedures for Sexual Activity	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1007	Lab Tests During Pregnancy	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1008	Diagnostic Studies During Pregnancy	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1011	Pregnancy Test	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1012	Complications of Pregnancy, Childbirth and the Puerperium	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1016	Congenital or Acquired Absence of Cervix	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1017	Procedures Used to Indicate Sexual Activity	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1018	Diagnoses Used to Indicate Sexual Activity	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.112.11.1024	Absence of Cervix	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.112.11.1025	Absence of Cervix	active	2021-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.112.11.1026	Absence of Cervix	active	2023-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1073	Osteoporosis Without Current Fracture	active	2017-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1074	Osteoporosis Without Current Fracture	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1200	Osteoporosis With Current Fracture	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1201	Osteoporosis With Current Fracture	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1202	DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1308	Frailty Diagnosis	active	2024-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1309	Frailty Diagnosis	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1310	Frailty Symptom	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1311	Frailty Symptom	active	2023-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1038	Osteoporosis Without Current Fracture	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1050	Osteoporosis With Current Fracture	active	2018-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1051	DXA (Dual energy Xray Absorptiometry) Scan	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1074	Frailty Diagnosis	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1075	Frailty Symptom	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1021	Narcolepsy	active	2018-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1023	Narcolepsy	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1024	Neurologic impairment	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1025	Neurologic impairment	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1026	Neurologic impairment	active	2021-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.12.1011	Narcolepsy	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.12.1012	Neurologic impairment	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1149	Substance Use Disorder Long Acting Medication	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.115.11.1248	Retinal or Dilated Eye Exam	active	2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.115.12.1088	Retinal or Dilated Eye Exam	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1150	Substance Use Disorder Short Acting Medication	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1151	Substance Use Disorder Long Acting Medication Administration	active	2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1152	Substance Use Disorder Short Acting Medication Administration	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1155	Substance Use Disorder Short Acting Medication Administration	active	2023-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1156	Substance Use Disorder Long Acting Medication Administration	active	2021-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1157	Substance Use Disorder Short Acting Medication Administration	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1163	Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine	active	2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1164	Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine	active	2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1165	Hospice Diagnosis	active	2022-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1166	Hospice Diagnosis	active	2022-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1167	Palliative Care Diagnosis	active	2022-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1168	Palliative Care Diagnosis	active	2022-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1169	Palliative Care Diagnosis	active	2022-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1031	Hyperthyroidism	active	2018-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1033	Hyperthyroidism	active	2018-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1034	Hyperparathyroidism	active	2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1036	Hyperparathyroidism	active	2018-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.12.1015	Hyperthyroidism	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.12.1016	Hyperparathyroidism	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1170	Atomoxetine	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1171	Clonidine	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1172	Dexmethylphenidate	active	2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1173	Dextroamphetamine	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1174	Lisdexamfetamine	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1176	Methylphenidate	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1177	Lower Body Fractures Excluding Ankle and Foot	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1178	Lower Body Fractures Excluding Ankle and Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1179	Malignant Neoplasms of Lower and Unspecified Limbs	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.118.11.1042	Counseling for Physical Activity	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.118.11.1077	Falls Screening	active	2018-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.118.11.1097	CT Colonography	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.118.11.1220	Frailty Device SNOMED	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.118.12.1028	Falls Screening	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.118.12.1035	Counseling for Physical Activity	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.118.12.1300	Frailty Device	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1180	Malignant Neoplasms of Lower and Unspecified Limbs	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1181	Mechanical Complications Excluding Upper Body	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1182	Mechanical Complications Excluding Upper Body	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1183	Partial Arthroplasty of Hip	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1184	Partial Arthroplasty of Hip	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1188	Removal, Revision and Supplement Procedures of the Lower Body and Spine	active	2022-12	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1189	Removal, Revision and Supplement Procedures of the Lower Body and Spine	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1190	Antibiotic Medications for Upper Respiratory Infection	active	2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1193	Malignant Neoplasms	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1194	Malignant Neoplasms	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1196	Atherosclerosis of the Extremities	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1197	Atherosclerosis of the Extremities	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1198	Atherosclerosis of the Extremities	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1199	Lower Extremity Neurological Assessment Result or Finding	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.11.1001	Disorders of the Immune System	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.11.1003	Disorders of the Immune System	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.11.1004	HIV Viral Load	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.11.1008	HIV 2	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.11.1010	HIV 2	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.11.1011	Severe Combined Immunodeficiency	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.11.1012	Severe Combined Immunodeficiency	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.12.1001	Disorders of the Immune System	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.12.1002	HIV Viral Load	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.12.1003	HIV	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.120.12.1007	Severe Combined Immunodeficiency	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1200	Lower Extremity Neurological Tests	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1201	Lower Extremity Visual Inspection Result or Finding	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1202	Lower Extremity Visual Inspection Test	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1203	Monofilament Test Result or Finding	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1204	Monofilament Tests	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1205	Pedal Pulse Result or Finding	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1206	Peripheral Neuropathy	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1207	Peripheral Neuropathy	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1208	Peripheral Neuropathy	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1209	Amputation of Bilateral Feet	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.121.11.1011	Consultant Report	active	2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.121.11.1028	BMI percentile	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.121.11.1030	Height	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.121.11.1031	Weight	active	2017-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.121.12.1006	Consultant Report	active	2024-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.121.12.1012	BMI percentile	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.121.12.1014	Height	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.121.12.1015	Weight	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1210	Amputation of Bilateral Feet	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1211	Amputation of Bilateral Feet	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1212	Amputation of Left Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1213	Amputation of Left Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1214	Amputation of Left Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1215	Amputation of Right Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1216	Amputation of Right Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1217	Amputation of Right Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1218	Amputation of Unspecified Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1219	Amputation of Unspecified Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.122.11.1003	Ambulatory	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.122.12.1003	Ambulatory	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1220	Foot Assessment With Abnormal Result or Finding	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1221	Foot Assessment With Abnormal Result or Finding	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1222	Acquired Absence of Bilateral feet	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1223	Acquired Absence of Bilateral feet	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1224	Acquired Absence of Left Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1225	Acquired Absence of Left Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1226	Acquired Absence of Left Foot	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1227	Acquired Absence of Right Foot	active	2023-07	us